Insider · CIK 0001745995

Corcoran Gavin

Reports to the SEC for 2 companies · WEST CHESTER, PA

sec.gov

Transactions

Companies

Filings

CIK

0001745995

Forms 4 and 5

Insider transactions

16 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-05	VRCAVerrica Pharmaceuticals Inc. · Stock Option (right to buy)A Award	Director	AAward	+16K sh	—	—	16,000
2025-06-05	VRCAVerrica Pharmaceuticals Inc. · Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2025-03-31	VRCAVerrica Pharmaceuticals Inc. · Stock Option (right to buy)A Award	Director	AAward	+17.5K sh	—	—	17,502
2021-04-15	Sio Gene Therapies Inc.Stock Option (Right to Buy)A Award	Chief R&D Officer	AAward	+244K sh	—	—	244,300
2021-03-17	Sio Gene Therapies Inc.Restricted Stock UnitsD Disposition to Issuer	Chief R&D Officer	DDisposition to Issuer	−16K sh	—	—	0
2021-03-17	Sio Gene Therapies Inc.A Award	Chief R&D Officer	AAward	+16K sh	—	—	25,792
2020-06-12	Sio Gene Therapies Inc.Restricted Stock UnitsD Disposition to Issuer	Chief R&D Officer	DDisposition to Issuer	−16K sh	—	—	16,001
2020-06-12	Sio Gene Therapies Inc.F Tax Payment	Chief R&D Officer	FTax Payment	−6,211 sh	$3.46	−$21.5K	9,791
2020-06-12	Sio Gene Therapies Inc.A Award	Chief R&D Officer	AAward	+16K sh	—	—	16,002
2020-04-15	Sio Gene Therapies Inc.Stock Option (Right to Buy)A Award	Chief R&D Officer	AAward	+63.7K sh	—	—	63,700
2020-04-15	Sio Gene Therapies Inc.Restricted Stock UnitsA Award	Chief R&D Officer	AAward	+42.4K sh	—	—	42,400
2019-09-21	Sio Gene Therapies Inc.Restricted Stock UnitsA Award	Chief R&D Officer	AAward	+32K sh	—	—	32,003
2019-04-15	Sio Gene Therapies Inc.Stock Option ( Right to Buy)A Award	Chief R&D Officer	AAward	+767K sh	—	—	767,000
2019-04-15	Sio Gene Therapies Inc.Stock Option ( Right to Buy)A Award	Chief R&D Officer	AAward	+200K sh	—	—	200,000
2018-07-16	Sio Gene Therapies Inc.Employee Stock Option (Right to Buy)A Award	Chief R&D Officer	AAward	+200K sh	—	—	200,000
2018-07-16	Sio Gene Therapies Inc.Employee Stock Option (Right to Buy)A Award	Chief R&D Officer	AAward	+250K sh	—	—	250,000

Recent filings

Accepted (ET)
Jun 94
Corcoran Gavin0001745995-26-000002
SEC(opens sec.gov)
Jun 94
Corcoran Gavin0001415889-25-016290
SEC(opens sec.gov)
Apr 24
Corcoran Gavin0001415889-25-009654
SEC(opens sec.gov)
Apr 194
Corcoran Gavin0001636050-21-000045
SEC(opens sec.gov)
Mar 194
Corcoran Gavin0001636050-21-000029
SEC(opens sec.gov)
Jun 154
Corcoran Gavin0001209191-20-036804
SEC(opens sec.gov)
Apr 174
Corcoran Gavin0001209191-20-025017
SEC(opens sec.gov)
Sep 244
Corcoran Gavin0001636050-19-000086
SEC(opens sec.gov)
Apr 174
Corcoran Gavin0001209191-19-025191
SEC(opens sec.gov)
Jul 204
Corcoran Gavin0001209191-18-043532
SEC(opens sec.gov)

Companies

Address

C/O VERRICA PHARMACEUTICALS INC. 44 WEST GAY STREET, SUITE 400

WEST CHESTER, PA, 19380